Physicians' Cancer Chemotherapy Drug Manual 2020Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer Chemotherapy Drug Manual 2020 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. |
Contents
CHAPTER 1 Principles of Cancer Chemotherapy | 1 |
CHAPTER 2 Chemotherapeutic and Biologic Drugs | 5 |
CHAPTER 3 Guidelines for Chemotherapy and Dosing Modifications | 537 |
CHAPTER 4 Common Chemotherapy Regimens in Clinical Practice | 565 |
Other editions - View all
Physicians' Cancer Chemotherapy Drug Manual 2020 Edward Chu,Vincent T. DeVita Jr. Limited preview - 2019 |
Common terms and phrases
21 days 5-Fluorouracil ABSORPTION activity administered agent and/or approximately avoided binding blood Breastfeeding cancer caution in patients cell characterized chemotherapy Cisplatin CLASSIFICATION Clin Oncol Closely monitor combination CONSIDERATIONS cycle every 21 day 1 Repeat decreased develop diarrhea disease DISTRIBUTION DOSAGE RANGE dose reduction Doxorubicin DRUG INTERACTION drug levels DRUG MANUFACTURER effects elimination enzymes et al FDA-approved function given half-life hepatic dysfunction Ifosfamide imatinib impairment increased Increased expression increased risk INDICATIONS inhibition inhibitor IV on day leading least liver lymphoma MECHANISM OF ACTION MECHANISM OF RESISTANCE metabolism metabolites metastatic mg PO mg PO daily mg/kg mg/m2 IV mild moderate Monitor months mutations Myelosuppression necessary observed occur once oral Paclitaxel parent drug patients potential Pregnancy category presence prior progression reactions Recommended dose regimen renal Repeat cycle resulting serum setting signaling skin SPECIAL studied syndrome therapy TOXICITY TRADE NAME treatment tumor usually Vincristine weekly weeks